Compounds > piracetam
Page last updated: 2024-11-02

piracetam and Atherosclerotic Parkinsonism

piracetam has been researched along with Atherosclerotic Parkinsonism in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sano, M1
Stern, Y1
Marder, K1
Mayeux, R1

Trials

1 trial available for piracetam and Atherosclerotic Parkinsonism

ArticleYear
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:3

    Topics: Aged; Aged, 80 and over; Cognition Disorders; Double-Blind Method; Humans; Middle Aged; Parkinson Di

1990

Other Studies

1 other study available for piracetam and Atherosclerotic Parkinsonism

ArticleYear
[Piracetam in the modern pharmacotherapy of the Parkinson syndrome].
    Die Medizinische Welt, 1978, Sep-01, Volume: 29, Issue:35

    Topics: Female; Humans; Middle Aged; Parkinson Disease, Secondary; Piracetam; Pyrrolidinones; Tremor

1978